Fulminant liver failure secondary to submassive hepatic necrosis in a patient treated with Orlistat. A case report

Alberto-Martínez-Insfran, Luis; Alconchel-Gago, Felipe; Parrilla-Paricio, Pascual

RICSMUR Principal
→
02. Servicio Murciano de Salud (SMS)
→
02.01. Área de Salud I Murcia Oeste
→
02.01.01. Investigación y comunicación científica
→
Ver ítem

dc.contributor.author	Alberto-Martínez-Insfran, Luis
dc.contributor.author	Alconchel-Gago, Felipe
dc.contributor.author	Parrilla-Paricio, Pascual
dc.date.accessioned	2026-01-19T16:05:45Z
dc.date.available	2026-01-19T16:05:45Z
dc.date.issued	2019
dc.identifier.citation	Martínez Insfran LA, Alconchel Gago F, Parrilla Paricio P. Fulminant liver failure secondary to submassive hepatic necrosis in a patient treated with Orlistat. A case report. Rev Esp Enferm Dig [Internet]. 2018 [citado 13 de enero de 2026];111. Disponible en: https://online.reed.es/fichaArticulo.aspx?iarf=685768740235-414270195164
dc.identifier.issn	1130-0108
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/23725
dc.description.abstract	Orlistat is an intestinal lipase inhibitor drug that is recommended in obese patients along with a hypocaloric diet. Although the most frequent secondary effect is steatorrhea, fulminant liver failure has also been associated with this drug, which has required liver transplantation in 3 patients. We present the case of a 42-year-old obese male.
dc.language.iso	eng
dc.publisher	ARAN EDICIONES, S A
dc.rights	Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/deed.es	*
dc.subject.mesh	Adult
dc.subject.mesh	Anti-Obesity Agents/adverse effects
dc.subject.mesh	Fatty Liver/drug therapy
dc.subject.mesh	Humans
dc.subject.mesh	Liver Failure, Acute/chemically induced
dc.subject.mesh	Male
dc.subject.mesh	Massive Hepatic Necrosis/chemically induced/complications
dc.subject.mesh	Obesity/drug therapy
dc.subject.mesh	Orlistat/adverse effects
dc.title	Fulminant liver failure secondary to submassive hepatic necrosis in a patient treated with Orlistat. A case report
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	30325196
dc.relation.publisherversion	https://online.reed.es/fichaArticulo.aspx?iarf=685768740235-414270195164
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.identifier.doi	10.17235/reed.2018.5740/2018
dc.journal.title	Revista Española de Enfermedades Digestivas
dc.identifier.essn	2340-4167